SPOTLIGHT: Fast growth for vaccine market

RNCOS estimates that the global vaccines market should hit $21 billion by 2010. Analysts say that the vaccine market has been growing at a much faster clip than pharma in general. Release

Suggested Articles

Merck & Co. inked a series of deals to advance three COVID-19 projects, trailing some of its large pharma peers into the industrywide research effort.

With a new £131 million contribution from the U.K. government, VMIC aims to both speed up and expand on its prior ambitions.

AstraZeneca scored a $1 billion contribution from the United States for development, production and delivery of its potential COVID-19 vaccine.